$4.57
-2.16-32.10%
At close: May 15, 5:00 PM EST
$4.57
N/A
After Hours: 6:15 PM EST
Aardvark Therapeutics Inc Earnings Estimates
AARDNASDAQ
Aardvark Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:AARD
Aardvark Therapeutics (AARD) is scheduled to report Q2 earnings on August 12, 2026. Analysts estimate EPS of $-0.87 and quarterly revenue of N/A.
In the most recent quarter (Q1), Aardvark Therapeutics reported EPS of $-0.99, missing estimates of $-0.89 by 0.11%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, Aardvark Therapeutics has averaged an EPS surprise of 0.09% and a revenue surprise of 0.00%.
Earnings Date
Aug 12
EPS Estimate
$-0.870
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Aardvark Therapeutics Earnings History
Analyze the earnings history of Aardvark Therapeutics using advanced sorting and filters.
Loading calendar...
Aardvark Therapeutics (AARD) Earnings Per Share
The chart below shows Aardvark Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Aardvark Therapeutics (AARD) Revenue
The chart below shows Aardvark Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Aardvark Therapeutics (NASDAQ:AARD) reporting earnings?
Aardvark Therapeutics (AARD) is scheduled to report earnings on August 12, 2026. The last reported earnings were for reported on May 7, 2026 for Q1.
What were the latest earnings per share (EPS) for Aardvark Therapeutics (NASDAQ:AARD)?
The Actual EPS was $-0.99, which missed the estimate of $-0.89.
What were Aardvark Therapeutics’s (NASDAQ:AARD) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
